In the current session, UiPath Inc. (NYSE: PATH) is trading at $9.88, after a 2.23% decrease. Over the past month, the stock decreased by 30.01%, and in the past year, by 19.72%. With performance like ...

Nebius and UiPath are promising AI companies, but one's fundamentals shine brighter than the other's.

UiPath (NYSE:PATH) introduced new AI tools for healthcare at the ViVE 2026 conference. The offerings include medical records summarization, claim denial prevention, and prior authorization support.

UiPath (PATH) closed the most recent trading day at $10.17, moving -5.83% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 1.04% for the day.

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

UiPath handily beat earnings expectations and guided for strong sequential growth. The company appears to be integrating large language models into its platform in a way that's attracting customers.

ServiceNow and UiPath could become agentic AI leaders.

UiPath (NYSE:PATH) has agreed to acquire WorkFusion, a provider of AI driven financial crime compliance software for banks. The deal is aimed at expanding UiPath's automation capabilities into ...